HCW Biologics Inc. Common Stock

HCWBNASDAQ • USD
1.17 USD
↗ 0.05 (4.46%)AT CLOSE (03:59 PM EDT)
1.12
↘ 0.05 (4.27%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
1.12
↘ 0.05 (4.27%)
🔴Market: CLOSED

HCW Biologics Inc. Common Stock (HCWB) trades at $1.17 per share. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, HCWB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$1.12
High?$1.19
Low?$1.09
Prev. Close?$1.12
Volume?80.6K
Avg. Volume?606.2K
VWAP?$1.13
Rel. Volume?0.13x
Bid / Ask
Bid?$1.08 × 100
Ask?$1.23 × 200
Spread?$0.15
Midpoint?$1.16
Valuation & Ratios
Market Cap?2.6M
Shares Out?N/A
Float?1.7M
Float %?90.7%
P/E Ratio?N/A
P/B Ratio?0.35
EPS?-$9.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Employees
35
Market Cap
2.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-20
Address
2929 N COMMERCE PKWY
MIRAMAR, FL 33025
Phone: 954-842-2024
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
90
Short Sent.?
71
Piotroski F-Score?2/9Weak
Altman Z-Score?-7.17Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.66%Low
Short Interest?60.9K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume1.3M
Settlement Date2026-09-30
Financial Health
Current Ratio?0.06Weak
Quick Ratio?0.06Weak
Cash Ratio?0.04Low
Debt/Equity?0.88Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.35CHEAP▾
P/S?
Peers
100
S&P
97
0.39CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.2CHEAP▾
EV/Sales?
Peers
100
S&P
88
1.26CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-288.3%WEAK▾
ROA?
S&P
3
-80.0%WEAK▾
Cash Flow & Enterprise
FCF?$-12136822
Enterprise Value?$8.4M
Fundamentals ratios updated end of day